35.21 USD
-0.33 (-0.93%)
35.21 USD
0 (0%)
INDV gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While INDV has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on INDV.
1. Profitability
1.1 Basic Checks
INDV had positive earnings in the past year.
INDV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.62%, INDV belongs to the top of the industry, outperforming 90.05% of the companies in the same industry.
INDV's Return On Invested Capital of 50.62% is amongst the best of the industry. INDV outperforms 100.00% of its industry peers.
INDV had an Average Return On Invested Capital over the past 3 years of 43.06%. This is significantly above the industry average of 12.85%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(50.62%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
With an excellent Profit Margin value of 10.34%, INDV belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
In the last couple of years the Profit Margin of INDV has declined.
INDV has a better Operating Margin (24.49%) than 91.62% of its industry peers.
In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
Looking at the Gross Margin, with a value of 85.51%, INDV belongs to the top of the industry, outperforming 89.01% of the companies in the same industry.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
Compared to 1 year ago, INDV has less shares outstanding
INDV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.77 indicates that INDV is not a great score, but indicates only limited risk for bankruptcy at the moment.
INDV has a Altman-Z score of 2.77. This is in the better half of the industry: INDV outperforms 64.40% of its industry peers.
The Debt to FCF ratio of INDV is 2.68, which is a good value as it means it would take INDV, 2.68 years of fcf income to pay off all of its debts.
INDV's Debt to FCF ratio of 2.68 is amongst the best of the industry. INDV outperforms 91.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.77 |
ROIC/WACC5.39
WACC9.39%
2.3 Liquidity
INDV has a Current Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
INDV has a worse Current ratio (0.96) than 85.86% of its industry peers.
A Quick Ratio of 0.79 indicates that INDV may have some problems paying its short term obligations.
INDV has a worse Quick ratio (0.79) than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 239.13% over the past year.
The earnings per share for INDV have been decreasing by -53.19% on average. This is quite bad
INDV shows a decrease in Revenue. In the last year, the revenue decreased by -0.25%.
INDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.64% yearly.
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
INDV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.72% yearly.
INDV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
INDV is valuated rather expensively with a Price/Earnings ratio of 17.96.
Compared to the rest of the industry, the Price/Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 82.72% of the companies listed in the same industry.
INDV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.38.
With a Price/Forward Earnings ratio of 12.57, INDV is valued correctly.
INDV's Price/Forward Earnings ratio is rather cheap when compared to the industry. INDV is cheaper than 84.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.83. INDV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.96 | ||
| Fwd PE | 12.57 |
4.2 Price Multiples
83.25% of the companies in the same industry are more expensive than INDV, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INDV indicates a somewhat cheap valuation: INDV is cheaper than 79.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.63 | ||
| EV/EBITDA | 13.7 |
4.3 Compensation for Growth
INDV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INDV has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INDV's earnings are expected to grow with 125.91% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y229.55%
EPS Next 3Y125.91%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
35.21
-0.33 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners93.08%
Inst Owner Change240.03%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap4.40B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84.62
Price Target38.61 (9.66%)
Short Float %4.77%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)159.52%
PT rev (3m)159.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)75.01%
EPS NY rev (3m)76.75%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.51%
Revenue NY rev (3m)12.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.96 | ||
| Fwd PE | 12.57 | ||
| P/S | 3.73 | ||
| P/FCF | 36.63 | ||
| P/OCF | 24.42 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.7 |
EPS(TTM)1.96
EY5.57%
EPS(NY)2.8
Fwd EY7.96%
FCF(TTM)0.96
FCFY2.73%
OCF(TTM)1.44
OCFY4.09%
SpS9.45
BVpS-1.66
TBVpS-1.67
PEG (NY)0.02
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.77 |
F-Score8
WACC9.39%
ROIC/WACC5.39
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1034.05%
EBIT Next 3Y143.47%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PLC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
Can you provide the valuation status for INDIVIOR PLC?
ChartMill assigns a valuation rating of 7 / 10 to INDIVIOR PLC (INDV). This can be considered as Undervalued.
What is the profitability of INDV stock?
INDIVIOR PLC (INDV) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for INDV stock?
The Price/Earnings (PE) ratio for INDIVIOR PLC (INDV) is 17.96 and the Price/Book (PB) ratio is -21.24.
What is the financial health of INDIVIOR PLC (INDV) stock?
The financial health rating of INDIVIOR PLC (INDV) is 4 / 10.